Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma
19 January 2018
Melanoma Institute Australia is delighted to be the charity partner for the Toyota Country Music Festival 2018 in Tamworth, with the traditional festival hat giveaway to raise vital funds for research into melanoma prevention and treatment.
Melanoma is the most deadly form of skin cancer. Australia has one of the highest rates in the world with one person dying from the disease every five hours. It is the most common cancer affecting 15 to 39 year olds and incidence in the over 60s age bracket is also increasing. 14,000 Australians are expected to be diagnosed with melanoma this year.
Melanoma Institute Australia is leading the world charge to prevent melanoma and find a cure, and funds raised at this year’s Toyota Country Music Festival through their annual hat fundraiser will help fuel ongoing research.
Toyota ambassadors, including Lee himself and The McClymonts, will be making surprise appearances to support this cause as well during the Festival to meet fans and show their support in raising awareness of sun safety.
Prevention is the key to saving lives from melanoma. All Australians are urged to wear SPF 50+ sunscreen and re-apply at least every two hours or after swimming or activity; cover up with a broad-brimmed hat, long pants and shirt and sunglasses; and seek shade in the heat of the day.
Hats will be available daily at the Toyota Fanzone at 10am, 12pm, 2pm and 4pm in exchange for a two-dollar donation with all proceeds going to Melanoma Institute Australia
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.